首页> 美国卫生研究院文献>Orphanet Journal of Rare Diseases >Analysis of LPI-causing mutations on y+LAT1 function and localization
【2h】

Analysis of LPI-causing mutations on y+LAT1 function and localization

机译:LPI引起的y + LAT1功能和定位突变的分析

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Backgroundy+LAT1, encoded by SCL7A7, is the protein mutated in Lysinuric Protein Intolerance (LPI), a rare metabolic disease caused by a defective cationic amino acid (CAA, arginine, lysine, ornithine) transport at the basolateral membrane of intestinal and renal tubular cells. The disease is characterized by protein-rich food intolerance with secondary urea cycle disorder, but symptoms are heterogeneous with lung and immunological complications that are not explainable by the CAA transport defect. With the exception of the Finnish founder mutation (c.895-2A > T, LPIFin), LPI-causative mutations are heterogeneous and genotype-phenotype correlations have not been found. Here we addressed system y+L-mediated arginine uptake in monocytes from three LPI Italian patients and in lymphoblasts carrying the same mutations; in parallel, the genetic defects carried by the patients were reproduced as eGFP-tagged y+LAT1 mutants in transfected CHO cells to define the function and localization protein.
机译:由SCL7A7编码的Backgroundy + LAT1是在赖氨酸尿酸蛋白耐性(LPI)中突变的蛋白,赖氨酸尿酸蛋白不耐症(LPI)是一种由于阳离子氨基酸(CAA,精氨酸,赖氨酸,鸟氨酸)在肠和肾小管的基底外侧膜运输而引起的罕见代谢疾病细胞。该疾病的特征是对继发性尿素循环紊乱的富含蛋白质的食物不耐受,但症状与肺脏和免疫学并发症异质,CAA运输缺陷无法解释。除芬兰创始人突变(c.895-2A→> T,LPIFin)外,LPI致病突变是异质的,尚未发现基因型与表型的相关性。在这里,我们研究了来自三名意大利LPI患者的单核细胞和携带相同突变的淋巴母细胞中系统y + L介导的精氨酸摄取。同时,将患者携带的遗传缺陷复制为转染的CHO细胞中带有eGFP标签的y + LAT1突变体,以定义功能和定位蛋白。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号